In spite of its effective anti-diabetes properties, the clinical application of natural GLP-1 is hindered by its fast degradation by the dipeptidyl peptidase-4 enzyme in vivo, resulting in a half-life around 2 min [7]. The gene discussed is GLP1R; the disease is diabetes mellitus.